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Abstract 
 
In recent years, the dynamic nature of mitochondria has been discovered to be critical for 
their function.   Here we discuss the molecular basis of mitochondrial fusion, its 
protective role in neurodegeneration, and its importance in cellular function.  The 
mitofusins Mfn1 and Mfn2, GTPases localized to the outer membrane, mediate outer 
membrane fusion.  OPA1, a GTPase associated with the inner membrane, mediates 
subsequent inner membrane fusion.  Mutations in Mfn2 or OPA1 cause 
neurodegenerative diseases.  Mouse models with defects in mitochondrial fusion genes 
have provided important avenues for understanding how fusion maintains mitochondrial 
physiology and neuronal function.  Mitochondrial fusion enables content mixing within a 
mitochondrial population, thereby preventing permanent loss of essential components.  
Cells with reduced mitochondrial fusion, as a consequence, show a subpopulation of 
mitochondria that lack mtDNA nucleoids.  Such mtDNA defects lead to respiration-
deficient mitochondria, and their accumulation in neurons leads to impaired outgrowth of 
cellular processes and ultimately neurodegeneration. 
  
 Mitochondria are now recognized as highly dynamic organelles that move 
throughout a cell and constantly fuse and divide.  Studies over the last several years 
indicate that these membrane-remodeling processes promote homogenization of the 
mitochondrial population by content mixing and thereby preserve mitochondrial 
function.1, 2  Mitochondrial fusion is clearly an important physiological activity; 
mutations in fusion genes in humans cause neurodegenerative diseases, and mice with 
reduced mitochondrial fusion show severe defects in multiple cell types.  Current 
research in our lab focuses on the mechanics of mitochondrial fusion and the 
pathophysiological significance of this process. 
 
Molecular mechanism 
 Fusion between two mitochondria entails the coordinated merging of four 
membranes–two outer membranes and two inner membranes.  In mammals, three large 
GTPases are required for this function.  The mitofusins, Mfn1 and Mfn2, are highly 
homologous, integral outer membrane proteins with the bulk of the polypeptide chain 
facing the cytoplasm.  Both Mfn1 and Mfn2 can form protein complexes with themselves 
or each other.3  Such physical interactions between Mfns on opposing mitochondria serve 
to tether the outer membranes together.4 In the absence of Mfns, neither outer membrane 
fusion nor inner membrane fusion occurs.4, 5  It is currently unclear how Mfns promote 
outer membrane fusion beyond the initial tethering step.  The presence of GTPase 
domains in Mfns suggests that they actively promote membrane merger via GTP 
hydrolysis. 
 OPA1, the third mitochondrial fusion protein, presents a more complicated story.  
Eight mRNA splice forms exist in mice and humans.  In addition, post-translational 
cleavage of each mRNA product results in multiple protein isoforms.  The “long” 
isoforms are integral inner membrane proteins, traversing the membrane once, whereas 
the “short” isoforms reside in the intermembrane space and are thought to be peripherally 
associated with the inner membrane. Under normal conditions, neither class of isoforms 
is sufficient to promote fusion.  Rather, both a long and a short form of OPA1 must be 
present for mitochondrial fusion to occur.6  By marking mitochondria with 
photoactivatable fluorescent markers, we have developed live imaging assays for outer 
membrane fusion versus full fusion.  In mammalian cells, outer membrane fusion occurs 
in the absence of OPA1, but inner membrane fusion does not.5   Therefore, although outer 
and inner mitochondrial membrane fusion are normally coordinated, the two processes 
can be functionally separated.  These results indicate that mitofusins are essential for 
outer membrane fusion, whereas OPA1 functions subsequently in inner membrane 
fusion. 
 
Pathophysiology 
 Human genetic studies show that mitochondrial fusion is particularly important to 
neurons.1  Mutations in Mfn2 cause Charcot-Marie-Tooth disease type 2A (CMT2A), a 
peripheral neuropathy that primarily impairs motor and sensory neurons with the longest 
axons.7  As a result, patients have the most severe and earliest symptoms in the distal 
extremities.  Mutations in OPA1 cause autosomal dominant optic atrophy (DOA), a 
degenerative disease of the optic nerve.8, 9  Whereas some pathological OPA1 mutants 
may be gain-of-function alleles, it is clear that at least some of the alleles result in 
haploinsufficiency, suggesting that loss of fusion is causal.   
One question of great interest is why mutations in two mitochondrial fusion 
proteins cause such different diseases.  Possible explanations include tissue specificity of 
expression, redundancy of Mfn1 and Mfn2, differences in function between outer and 
inner membrane fusion, and specific non-fusion functions of either Mfn2 or OPA1.  
Whereas all of these are possible, it is important to note that studies of more families 
have revealed a greater overlap in clinical manifestations of CMT2A and DOA patients 
than previously recognized.1  DOA patients may present with peripheral neuropathies, 
whereas some CMT patients have optic atrophy.  In addition, both OPA1 and Mfn2 
mutations can cause cerebral and cerebellar abnormalities along with deafness, muscular 
dysfunction and psychiatric involvement.  Therefore, mutations in both mitochondrial 
fusion genes can indeed affect a large range of partially overlapping tissues. 
With both Mfn2 and OPA1 mutations, neuronal and muscular involvement is 
particularly widespread.  This pattern is similar to that seen in disease caused by 
mitochondrial DNA (mtDNA) mutations.  Interestingly, mtDNA deletions have been 
found in the muscle of a subset of DOA patients demonstrating myopathies.10, 11  This 
observation suggests that a new avenue of exploration is how mitochondrial fusion 
affects mtDNA integrity. 
 
Murine models 
 It is clear that much remains to be learned concerning the role of mitochondrial 
fusion in vivo, as well as the specific functions of Mfn1 versus Mfn2.  To address these 
issues, we have established conditional knockout mice for Mfn1 and Mfn2.  With this 
approach, we can determine the relative importance of Mfn1 versus Mfn2 in any given 
tissue, eliminate mitochondrial fusion in one tissue at a time, and ascertain whether this 
affects the organism as a whole.  Additionally, we can examine the cell biological 
consequences of mitochondrial fusion and determine how this pertains to the human 
diseases. 
 Deleting either Mfn1 or Mfn2 from all cells results in mid-gestational lethality.3  
When both Mfn1 and Mfn2 are eliminated, embryos die several days earlier.  All of these 
embryonic lethalities are due to insufficient mitochondrial fusion in the placenta, because 
wildtype placentas will support the development of mutant embryos through birth.12 
Without Mfn2, the trophoblast giant cells, which provide the interface between 
embryonic and maternal cells, do not develop normally.  However, mice that are Mfn2-/- 
but have a wildtype placenta survive for approximately 2 weeks after birth.  Mfn1-/- 
placentas have normal giant cells but must harbor defects in other cell layers, because 
once again, a wildtype placenta will rescue the embryonic lethality of Mfn1-/- mice.  In 
fact, these mice are not only born but survive into adulthood.  When both Mfn1 and Mfn2 
are missing in the embryo, though, the neonatal pups expire shortly after birth.  
Therefore, Mfn1 and Mfn2 serve both unique and redundant roles in development.  It is 
important to note that their unique roles do not seem to reflect a functional difference 
between the proteins, but rather a difference in their expression patterns (discussed later). 
 Since CMT2A and DOA are both neurodegenerative diseases, we were 
particularly interested in whether attenuation of mitochondrial fusion affects neuronal 
cells.  We found that Purkinje cells (PCs), the only efferent cells in the cerebellum, do not 
develop properly in the absence of Mfn2.12  In particular, their normally large dendritic 
arbors are only partially realized, thus limiting the formation of synapses. These defects 
eventually result in neuronal cell death, perhaps from lack of synaptic input. Thus Mfn2-
/- mice have no ability to relay information from the cerebellum to the rest of the central 
nervous system.  The subsequent lack of movement coordination prevents pups from 
feeding sufficiently and results in mortality at approximately two weeks of age.  
Interestingly, mitochondrial fusion is not only important for the development of PCs, it is 
also critical for their maintenance.  Deletion of Mfn2 from mature PCs causes massive 
degeneration of these neurons, resulting in severe ataxia in adult mice.  Interestingly, the 
cerebellum can be affected in both CMT2A and DOA patients. 
 In contrast to Mfn2, deletion of Mfn1 in either developing or mature PCs did not 
affect their mitochondria, and cerebellar function remained intact.  Why is there this 
specificity if Mfn1 and Mfn2 both serve to mediate mitochondrial outer membrane 
fusion?  RNA in situ analysis demonstrated a vastly greater level of Mfn2 expression in 
PCs than Mfn1, suggesting that normally, mitochondrial fusion in PCs is largely 
dependent on Mfn2 rather than Mfn1.  We therefore hypothesized that Mfn2 deletion 
would eliminate mitochondrial fusion whereas Mfn1 deletion would leave mitochondrial 
fusion activity largely intact, and it is this lack of fusion which causes the PC defects.12  
To test this idea, we established from mutant mice primary mixed cerebellar cultures, 
where we could exogenously express genes via lentiviral transduction.  As expected, 
Mfn2-/- PCs showed mitochondrial abnormalities and poor viability in culture.  However, 
transduction with either an Mfn2- or Mfn1-expressing lentivirus was equally effective at 
rescuing the PCs from cell death.  A fusion-defective mutant, Mfn2K109A, did not rescue 
the mutant phenotype.  Therefore, it is not a unique function of Mfn2 that is required in 
PCs.  It is simply that mitochondrial fusion in PCs in vivo depends largely on Mfn2 rather 
than Mfn1. 
 Our studies of Mfn2 mutants identified in CMT2A further elaborate this concept 
of functional interplay between Mfn1 and Mfn2.13  As an autosomal dominant disease, 
CMT2A generally involves mutation of only a single Mfn2 allele, so that both wildtype 
Mfn1 and Mfn2 are also present in patients.  Using Mfn1-null cells and Mfn2-null cells, 
we tested the ability of various Mfn2CMT2A alleles to form fusion-competent complexes 
with wildtype Mfns.  Strikingly, whereas many Mfn2CMT2A alleles promote mitochondrial 
fusion in Mfn2-null cells, they are non-functional in Mfn1-null cells.  This observation 
indicates that many Mfn2CMT2A alleles can promote fusion when coupled to Mfn1, but not 
with Mfn2.  In most tissues of CMT2A patients, mitochondrial fusion proceeds normally, 
because Mfn1/Mfn1 and Mfn2CMT2A/Mfn1 hetero-oligomeric complexes both support 
fusion.  However, in tissues with low Mfn1 expression, mitochondrial fusion would be 
essentially abolished, because both these sources of mitochondrial fusion depend on 
Mfn1 function. 
 
Cellular mechanisms 
 From a cell biological perspective, how does lack of mitochondrial fusion affect 
neuronal function and survival? Neurons are highly dependent on mitochondrial activity 
that is concentrated at dendritic and axonal terminals. Mitochondrial activity is required 
in dendritic spines for synapses to form and function properly.  Neuronal survival, in 
turn, is dependent on sufficient synaptic activity.  In both developing and adult PCs 
lacking Mfn2, however, the mitochondria were found to be clustered in the cell body 
instead of spread throughout the neurites.12  Furthermore, of those few mitochondria 
present, a large percentage was dysfunctional in their oxidative phosphorylation 
capabilities.  Therefore, the combination of mitochondrial mislocalization and 
dysfunction impacts cellular function. 
 Mitochondria normally move rapidly along microtubule tracks, much like cars 
along a road.  In fusion-deficient fibroblasts, though, time-lapse imaging shows that the 
fragmented mitochondria move with a more Brownian-like motion, without much net 
distance traveled.3 In addition, analyses of branching junctions in dendrites by electron 
microscopy reveal pile-ups of mitochondria, which prevent transport to downstream 
sites.12 The defect in directed movement (especially when long distances to synaptic 
termini must be traversed) and blockage of neurite junctions are likely to contribute to the 
congregation of mitochondria in the cell body of fusion-deficient neurons. 
In both cultured cells and tissues from animals, it has been demonstrated that lack 
of fusion often leads to defects in oxidative phosphorylation.  While the mechanism has 
not been fully elucidated, partial loss of mtDNA seems to contribute to these defects in 
cellular respiration. In wildtype cells, every mitochondrion typically contains at least one 
mtDNA nucleoid, as assessed by immunostaining with an anti-DNA antibody (Figure 
1A).  Fusion-deficient cells (Figure 1B, C), however, harbor a large percentage of 
mitochondria without any discernible DNA.12  Since these mitochondria cannot fuse to 
other mitochondria and exchange contents, they have no ability to regain the requisite, 
mtDNA-encoded electron transport chain proteins, and are thus respiration-defective.  
Interestingly, defects in cerebellar function are also found in a large percentage of 
patients harboring pathological mtDNA mutations.14, 15  
 In summary, mitochondrial fusion protects mitochondrial function, most likely by 
enabling exchange of contents.  In addition, fusion is important for mitochondrial 
motility, possibly through its effects on morphology.  When fusion is attenuated, the 
combination of mitochondrial mislocalization (especially in highly polarized cells such as 
neurons) and dysfunction negatively impacts cellular and tissue function.  In particular 
tissues at specific times, this can cause widespread consequences for the entire organism.  
For example, lack of fusion in adult Purkinje cells causes ataxia that the mice can largely 
tolerate.  In developing pups, though, lack of fusion in the same cells invariably results in 
lethality for the mice.  Because Mfn1 and Mfn2 play largely redundant roles in 
mitochondrial fusion, the expression patterns of the two proteins can dictate which tissues 
are selectively affected by the deletion of each gene.  Tissue specificity in the human 
diseases CTM2A and DOA may also reflect expression pattern differences.   
 
Figure legend 
 
Figure 1: Mitochondrial fusion prevents loss of mtDNA nucleoids. 
Mouse embryonic fibroblasts (MEFs) were stained with a monoclonal antibody against 
DNA.  Mitochondria were visualized with by enhanced green fluorescent protein (EGFP) 
targeted to the mitochondrial outer membrane.  In wildtype MEFs (A), each 
mitochondrial tubule contains one or more mtDNA nucleoids (small red spots).  In 
contrast, MEFs lacking Mfns (B) or OPA1 (C) contain fragmented mitochondria, and a 
large subpopulation of these lack mtDNA nucleoids.  Note that the anti-DNA staining 
also highlights nuclear DNA (large central oval).  Scale bar indicates 10 microns. 
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